Division of Thoracic Medicine

Medicine & Life Sciences

1. Taiwan 100%
2. Tuberculosis 83%
3. Lung 65%
4. Particulate Matter 58%
5. Chronic Obstructive Pulmonary Disease 48%
6. Multidrug-Resistant Tuberculosis 45%
7. Lung Neoplasms 37%
8. Non-Small Cell Lung Carcinoma 36%
9. Asthma 35%
10. Cohort Studies 34%
11. ErbB Receptors 32%
12. Air Pollution 32%
13. Connective Tissue Growth Factor 32%
14. Adenocarcinoma of Lung 31%
15. Pulmonary Tuberculosis 28%
16. Thrombin 27%
17. Protein-Tyrosine Kinases 25%
18. Pneumonia 23%
19. Interleukin-8 23%
20. Therapeutics 22%
21. Epithelial Cells 22%
22. Mycobacterium tuberculosis 21%
23. Population 20%
24. Fibroblasts 20%
25. Inflammation 20%
26. Transcription Factor AP-1 20%
27. Cyclooxygenase 2 19%
28. Mutation 19%
29. Polycyclic Aromatic Hydrocarbons 18%
30. Neoplasms 18%
31. Plasminogen Activator Inhibitor 1 18%
32. Meta-Analysis 17%
33. Pharmaceutical Preparations 17%
34. Obstructive Sleep Apnea 17%
35. Nanoparticles 16%
36. Phosphorylation 16%
37. A549 Cells 16%
38. Apoptosis 16%
39. Macrophages 16%
40. Pleural Effusion 15%
41. Confidence Intervals 15%
42. Vehicle Emissions 15%
43. Proteins 14%
44. Fibrosis 14%
45. Soot 14%
46. Sleep 13%
47. Zinc Oxide 13%
48. Interleukin-6 13%
49. Fluoroquinolones 13%
50. Coronavirus 13%
51. Phosphotransferases 13%
52. Survival 12%
53. Heart Rate 12%
54. Machine Learning 12%
55. Hong Kong 12%
56. Odds Ratio 12%
57. Extracellular Signal-Regulated MAP Kinases 12%
58. Peptidoglycan 12%
59. Occupational Groups 11%
60. Metals 11%
61. Systemic Lupus Erythematosus 11%
62. China 11%
63. Rifampin 11%
64. Carbon 11%
65. Systematic Reviews 11%
66. Small Interfering RNA 11%
67. Histone Deacetylase Inhibitors 11%
68. Autophagy 11%
69. Biomarkers 10%
70. Emphysema 10%
71. Phosphatidylinositol 3-Kinase 10%
72. Mortality 10%
73. Luciferases 10%
74. Neoplasm Metastasis 10%
75. Incidence 10%
76. Transforming Growth Factors 10%
77. National Health Programs 10%
78. Platelet Activation 10%
79. Intensive Care Units 10%
80. Complement Factor B 9%
81. Ovalbumin 9%
82. Disintegrins 9%
83. CCAAT-Enhancer-Binding Proteins 9%
84. Tumor Necrosis Factor-alpha 9%
85. butylidenephthalide 9%
86. Drug Therapy 9%
87. Endothelin-1 9%
88. Single-Chain Antibodies 9%
89. Rheumatoid Arthritis 9%
90. Malignant Pleural Effusion 9%
91. Diabetes Mellitus 8%
92. Drug Resistance 8%
93. p38 Mitogen-Activated Protein Kinases 8%
94. Toxicology 8%
95. Cell Survival 8%
96. Cytokines 8%
97. Welding 8%
98. Health 8%
99. Adrenal Cortex Hormones 8%